Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: The TiCAB trial

Heribert Schunkert*, Andreas Boening, Moritz Von Scheidt, Clarissa Lanig, Friederike Gusmini, Antoinette DeWaha, Constantin Kuna, Andreas Fach, Christina Grothusen, Martin Oberhoffer, Christoph Knosalla, Thomas Walther, Bernhard C. Danner, Martin Misfeld, Uwe Zeymer, Gerhard Wimmer-Greinecker, Matthias Siepe, Herko Grubitzsch, Alexander Joost, Andreas SchaeferLenard Conradi, Jochen Cremer, Christian Hamm, Rudiger Lange, Peter W. Radke, Rainer Schulz, Gunther Laufer, Philippe Grieshaber, Philip Pader, Tim Attmann, Michael Schmoeckel, Alexander Meyer, Tibor Ziegelhoffer, Rainer Hambrecht, Adnan Kastrati, Sigrid E. Sandner

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: The TiCAB trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science